5248042026-11-045248042026-11-042026-11-045248042026-11-042026-11-04AmalgamatedEntityDomain15248042026-11-04AmalgamatedEntityDomain15248042026-11-042026-11-04AmalgamatedEntityDomain25248042026-11-04AmalgamatedEntityDomain2xbrli:purexbrli:shares524804AUROBINDO PHARMA LIMITEDAUROPHARMANOTLISTEDINE406A01037NewAmalgamation/ Mergertrue2026-11-0418:00:002026-11-04AUROACTIVE PHARMA PRIVATE LIMITEDTransferorSubsidiaryAuroactive Pharma Private Limited (Auroactive Pharma), a wholly owned subsidiary of the Company, is the Transferor Company which was incorporated in India on January 9th, 2020. The turnover of Auroactive Pharma Private Limited for the FY ended 31.03.2026 was INR 793.5 million247000000100002470000001247000000100002470000001APITORIA PHARMA PRIVATE LIMITEDTransfereeMaterial SubsidiaryApitoria Pharma Private Limited (Apitoria Pharma), a wholly owned subsidiary of the Company, is the Transferee Company, which was incorporated in India on December 20th, 2017. The turnover of Apitoria Pharma Private Limited for the FY ended 31.03.2026 was INR 64,464.0 million99000000100009900000019900000010000990000001falsefalsetrueBoth the Companies are engaged in the manufacture of active pharmaceutical ingredients• The amalgamation is proposed to consolidate API businesses under a single entity • Improve the operational efficiency, optimise capacity utilisation of the Auroactive facility • Simplification of the Group’s corporate structureShares97:10000The total equity share capital of Auroactive Pharma Private Limited is INR 247,00,00,000 consisting of 24,70,00,000 equity shares of INR 10 each. 97 equity shares of Apitoria Pharma Private Limited having face value of INR 10 fully paid up shall be issued for every 10,000 equity shares of Auroactive Pharma Private Limited having face value of INR 10 each fully paid up. Accordingly, 23,95,900 equity shares of INR 10 each of Apitoria Pharma Private Limited shall be issued.Not applicable. The Scheme is between the wholly owned subsidiaries of the Company. The Company is not a party to the Scheme of Amalgamation and the shareholding pattern of the Company remains unchangedNil